{
  "id": "602c1fcc1cb411341a000120",
  "type": "summary",
  "question": "What is SAR425899?",
  "ideal_answer": "SAR425899 ia a dual glucagon-like peptide-1 receptor/glucagon receptor agonist.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31808298"
  ],
  "snippets": [
    {
      "text": "o evaluate the change in insulin sensitivity, \u03b2-cell function and glucose absorption after 28\u2009days of treatment with high and low doses of SAR425899, a novel dual glucagon-like peptide-1 receptor/glucagon receptor agonist, versus placebo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31808298",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dual glucagon-like peptide-1 receptor/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31808298",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": []
}